Oops, we invented a vaccine!
Serendipity, invention and innovation at X-VAX Reading time: 4 minutes [...]
About Arne
This author has not yet filled in any details.So far Arne has created 9 blog entries.
X-Vax Technology Raises $56 Million in Upsized Series A Financing to Advance Lead Herpes Vaccine Program
X-Vax Technology Raises $56 Million in Upsized Series A Financing [...]
Bucking dogma in HSV vaccine development
Bucking-dogma-HSV-vaccine-development-x-vax
Petro C et al., HSV-2 ΔgD elicits FcγR-effector antibodies that protect against clinical isolates, JCI Insight. 2016;1(12).
ncbi.nlm.nih.gov/pmc/articles/PMC4985247/
Bolland S, Pierce SK, Ups and downs in the search for a herpes simplex virus vaccine, eLife. 2015;4.
ncbi.nlm.nih.gov/pmc/articles/PMC4354104/
Petro C et al., Herpes simplex type 2 virus deleted in glycoprotein D protects against vaginal, skin and neural disease, eLife. 2015;4.
ncbi.nlm.nih.gov/pmc/articles/PMC4352706/
HSV-2 ΔgD elicits FcγR-effector antibodies that protect against clinical isolates
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4985247/
Ups and downs in the search for a Herpes simplex virus vaccine.
https://www.ncbi.nlm.nih.gov/pubmed/25756748
Herpes simplex type 2 virus deleted in glycoprotein D protects against vaginal, skin and neural disease
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4352706/